# EDGAR Filing Document

**Accession Number:** 0001695466
**File Stem:** 0000097476-26-000035
**Filing Date:** 2026-2
**Character Count:** 7471
**Document Hash:** d59837aa3b3b69276c6a903f9d1d0e52
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000097476-26-000035.hdr.sgml**: 20260202

**ACCESSION NUMBER**: 0000097476-26-000035

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260129

**FILED AS OF DATE**: 20260202

**DATE AS OF CHANGE**: 20260202

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Ilan Haviv
- **CENTRAL INDEX KEY:** 0001695466

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-03761
- **FILM NUMBER:** 26588177

**MAIL ADDRESS:**
- **STREET 1:** 12500 TI BOULEVARD
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75243
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TEXAS INSTRUMENTS INC
- **CENTRAL INDEX KEY:** 0000097476
- **STANDARD INDUSTRIAL CLASSIFICATION:** SEMICONDUCTORS & RELATED DEVICES [3674]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 750289970
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** P.O. BOX 660199
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75266
- **BUSINESS PHONE:** 9729953773

**MAIL ADDRESS:**
- **STREET 1:** 12500 TI BLVD
- **STREET 2:** PO BOX 660199
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75266

## Ex-24

```

AUTHORIZATION
I hereby authorize Katharine
Kane, Shannon S. Thompson,
Elizabeth M. Bedell, Tonya
Moran, Joseph S. Jablonski,
Erin E. Hilton and John
Whitney or any one of them
to sign and file on my
behalf any and all forms
required by the Securities
and Exchange Commission
pursuant to Section 16 of
the Securities Exchange
Act of 1934 (the "Exchange
Act") relating to the
reporting of beneficial
ownership of equity
securities of Texas
Instruments Incorporated
(the "Company"), and of
changes in such beneficial
ownership, as well as any
and all representation
letters that may be
required in connection
with sales by me of equity
securities of the Company,
together with any and all
amendments to the foregoing.
This authorization shall be
effective on and after the
date set forth below and
shall continue in effect,
unless earlier revoked by
me in writing, until I am
no longer required to file
such forms and letters
provided, however, that
this authorization shall
be deemed revoked with
respect to any individual
named above upon such
individual's termination
of active service with
the Company. On and after
the date set forth below,
any authorization
previously granted by
me concerning the
subject matter hereof
is revoked.
I acknowledge that
the persons authorized
hereunder are not
assuming, nor is the
Company assuming, any
of my responsibilities
to comply with Section
16 of the Exchange Act
and other relevant
securities laws.
Dated as of 3rd day of
December 2025.
Haviv Ilan

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Ilan Haviv<br><sub>(Last) (First) (Middle)</sub><br>12500 TI BOULEVARD<br><sub>(Street)</sub><br>DALLAS, TX 75243<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-01-29 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chairman, President & CEO_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>TEXAS INSTRUMENTS INC [ TXN ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2026-01-29 |  | A |  | 47952<sup>(1)</sup> | A | $0 | 214168 | D |  |
| Common Stock | 2026-01-30 |  | F |  | 9860 | D | $218.97 | 204308 | D |  |
| Common Stock |  |  |  |  |  |  |  | 32990 | I | By Spouse |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| NQ Stock Option (Right to Buy) | $218.97 | 2026-01-29 |  | A |  | 169862 |  | <sup>(2)</sup> | 2036-01-29 | Common Stock | 169862 | $0 | 169862 | D |  |

---

### Footnotes:

(1) Award of restricted stock units pursuant to 2024 Long-Term Incentive Plan.

(2) The stock option becomes exercisable in four equal installments beginning on January 29, 2027.

**Remarks:**
Exhibit 24 - Power of Attorney

**Signature:** /s/ Shannon Thompson, Attorney in Fact  
**Date:** 2026-02-02

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**